Prenatal Biochemical Screening Only Detects Half Of Chromosomal Abnormalities
Prenatal biochemical screening tests are widely used to look for chromosomal abnormalities in the fetus which can lead to serious handicap, or even death during gestation or in the first few days after birth. But these tests are only able to detect fewer than half of the total chromosomal abnormalities in the fetus. Dr. Francesca R. Grati, of the TOMA Laboratory, Busto Arsizio, Italy, says women should be better informed before deciding to undertake it. The researchers studied 115,576 prenatal diagnoses carried out during the last fourteen years. 84,847 were amniocenteses, usually carried out around the 16th week of pregnancy, and 30,729 chorionic villus samplings, which can be undertaken from 12 weeks into the pregnancy. Both these tests carry an increased risk of miscarriage, so the decision on whether or not to undertake them can be difficult to weigh up. read more
Read the whole article on Scientific Blogging
More from Scientific Blogging
Related
- Prenatal biochemical screening only detects half of chromosomal abnormalitiesSun, 1 Jun 2008, 19:00:28 EDT
- New test can detect both genetic and chromosomal abnormalities in embryosTue, 30 Jun 2009, 9:38:19 EDT
- Microarray analysis improves prenatal diagnosisMon, 17 Nov 2008, 10:58:58 EST
- Medications that block folic acid in pregnancy double risk of congenital malformations in fetusTue, 13 Oct 2009, 19:40:25 EDT
- Larger hospital units have lower miscarriage rates after invasive pregnancy testsTue, 7 Jul 2009, 11:09:35 EDT